Clinical trials
Phase 3 Carcinoma, Ovarian Epithelial trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 3 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 45 |
| Unknown status | 15 |
| Recruiting | 10 |
| Terminated | 8 |
| Active, not recruiting | 5 |
| Not yet recruiting | 5 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 6 |
| Medical Research Council | 6 |
| AGO Study Group | 4 |
| AstraZeneca | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| Fred Hutchinson Cancer Center | 3 |
| pharmaand GmbH | 3 |
| ImmunoGen, Inc. | 2 |
| Japanese Gynecologic Oncology Group | 2 |
| Lei Li | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Ovarian Epithelial | 89 |
| Ovarian Neoplasms | 55 |
| Fallopian Tube Neoplasms | 43 |
| Neoplasms | 12 |
| Breast Neoplasms | 11 |
| Testicular Neoplasms | 10 |
| Blast Crisis | 9 |
| Burkitt Lymphoma | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Leukemia, Myeloid, Accelerated Phase | 9 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.